Page 3 - Best Immunotherapy doctors: TOP 80 doctors

Dr. Alemdar specializes in medical oncology with extensive training at Akdeniz University – a leader in cancer research.

• Board-certified in medical oncology since 2018
• Practices at Medical Park Antalya Hospital Complex
• Over 20 years of experience of experience in internal medicine and oncology
• Trained at Akdeniz University – Turkey's premier cancer research center

Dr. Ozden specializes in medical oncology with over 27 years of experience of experience in internal medicine and oncology.

• Completed medical oncology subspecialty at Kocaeli University Faculty of Medicine
• Practiced internal medicine at multiple hospitals in Turkey
• Graduated from Istanbul University's Cerrahpaşa Faculty of Medicine

Dr. Salman specializes in immunotherapy for various cancers, integrating targeted therapies and cancer vaccines. He trained at prestigious institutions like Memorial Sloan Kettering Cancer Center.

• Associate Professor at Katip Çelebi University with 32 years of experience in medical oncology
• Academic visitor at Moffitt Cancer Center in Florida, USA
• Board member of Turkish Society of Medical Oncology and European Society of Medical Oncology
• Uses comprehensive genomic profiling for personalized treatment plans
• Active in clinical research and experimental medical therapies

Professor of Medical Oncology with over 29 years of experience of experience, specializing in advanced cancer treatments at İstinye University Liv Hospital Topkapı.

• Fellowship-trained in Medical Oncology at Trakya University
• Associate Professor and later Professor at Trakya University Faculty of Medicine
• Member of the Turkish Medical Oncology Association

Assoc. Prof. Nail Paksoy specializes in immunotherapy at Medipol Bahçelievler Hospital, with a strong background in medical oncology and allergy-immunology.

• ESMO Board Certified in Medical Oncology
• Participated in 8 international clinical trials for immunotherapy
• Published multiple studies on cancer treatment outcomes
• Fellowship-trained at Istanbul University Oncology Institute

Dr. Eckhart Weidmann heads the Hematology sector at Nordwest Clinic, specializing in blood disorder treatment with over 36 years of experience of practice.

• One of the top doctors for non-Hodgkin lymphoma
• Professor with extensive academic and clinical expertise
• Focuses on immunotherapy for blood disorders

Assoc. Prof. Atakan Topcu specializes in immunotherapy and targeted therapies for solid tumors at Medipol Acibadem District Hospital.

• Published over 50 scientific articles in oncology
• Member of European Society for Medical Oncology (ESMO)
• Expert in geriatric oncology and cancer-related malnutrition
• Fellowship-trained in medical oncology at Bezmialem Vakıf University

Dr. Lucía González Cortijo leads one of Spain's top oncology departments, specializing in immunotherapy for breast and gynecologic cancers.

• 20+ years focused exclusively on oncology
• Principal investigator in 20+ immunotherapy clinical trials
• Trained at MD Anderson Cancer Center Madrid
• Active member of ESMO and ASCO
• Leads La Vida en Rosa Foundation for women's cancer support

Associate Professor of Medical Oncology at İstinye University Liv Hospital Topkapı – specializes in immunotherapy for cancer treatment.

• 15 years of experience of experience in medical oncology
• Member of the American Society of Clinical Oncology (ASCO)
• Published multiple peer-reviewed articles on cancer treatment outcomes
• Focuses on immunotherapy for various cancer types

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Assoc. Prof. Ayse Irem Yasin specializes in immunotherapy for multiple cancer types at Medipol Acibadem District Hospital.

• Trained at top institutions including Cleveland Clinic and Harvard Medical School
• ESMO Board Certified – recognized expertise in oncology
• International observership at Italy's leading breast cancer unit
• Fellowship-trained medical oncologist with broad cancer experience

Prof. Ben Boursi leads groundbreaking research on microbiome's role in cancer therapy – his work is published in Science and featured at ASCO.

• Specializes in gastrointestinal oncology at Sheba Medical Center
• Trained at University of Pennsylvania and top US cancer centers
• Founder of ECOG-ACRIN Microbiome Working Group
• Develops predictive models for early cancer detection
• Board-certified in both Internal Medicine and Medical Oncology

Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.

He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.

He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Dr. Nir Kleinmann, MD, directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is an expert in minimally invasive urology and urologic oncology. His focus is the kidney and upper urinary tract. He was named among Israel’s Best Doctors for 2025–2026 by Forbes and ResultMed.

He is a pioneer of kidney‑sparing laser surgery. He uses a dual‑laser system with neodymium and holmium for complex tumors. His expertise includes UTUC, kidney and prostate cancer, kidney stones, and BPH.

His research includes the OLYMPUS trial on chemoablation for UTUC. He has more than 60 publications.

He is an Israeli board‑certified urologist. He is a Fellow of the American Endourology Society and a member of the Israeli Urological Association and the EAU. He completed fellowships in Endourology and Minimally Invasive Surgery at Thomas Jefferson University. He also completed a fellowship in Kidney Cancer Research at McMaster University.

Leader in immunotherapy research for melanoma and breast cancer – Dr. Soberino has contributed to groundbreaking drug approvals that revolutionized treatment.

• Key participant in trials leading to Pembrolizumab and Nivolumab-Ipilimumab approvals
• Specializes in overcoming hormone therapy resistance in breast cancer
• Active researcher in phase 1-3 clinical trials for new treatments
• Member of Vall d'Hebron's specialized Breast Cancer and Melanoma Units

World-renowned leader in Chronic Lymphocytic Leukemia (CLL) – Professor Bosch leads over 80 clinical trials on new treatments.

• Specializes in lymphomas and CLL with innovative treatment approaches
• Head of Hematology at IOB Institute of Oncology
• Published 100+ articles in top journals like NEJM and Nature Medicine
• Professor of Hematology at Vall d'Hebron University Hospital

Principal Investigator in clinical trials focusing on immunotherapy for gynecological cancers – Dr. Oaknin leads cutting-edge research at Hospital Quiron Barcelona.

• Specializes in ovarian, cervical, and endometrial cancer treatments
• Author of over 100 publications and presentations
• Executive board member of GEICO Group
• Faculty member for Gyn-Track in ESMO

Dr. Graus defined the first strict diagnostic criteria for paraneoplastic neurological syndromes – a key breakthrough in immunotherapy-related neurotoxicity.

• 44 years of experience specializing in neuro-oncology and immunotherapy complications
• Identified antibodies now used worldwide for diagnosing autoimmune neurological disorders
• Former Chief of Neurology at Hospital Clinic Barcelona
• Founder and past president of the European Association of Neuro-Oncology
• Fellowship-trained at Memorial Sloan-Kettering Cancer Center